NASDAQ$BTTC

Black Titan Corp · Q2 2022 earnings

Q2 2022 earnings · · Investor relations

Headline financials

Total Revenue

$76.7K

Previous: $29.2K+162.9%
EPS (adj)

-$3.60

Previous: -$3.40-5.9%
Free Cash Flow

-$1.77M

No prior period
Net Income

-$261K

Previous: -$77.8K-235.5%
Operating Income

-$261K

Previous: -$70.9K-267.8%
Gross Profit

$76.7K

Previous: $29.2K+162.9%
Cash & Equivalents

$6.42M

Previous: $15.9K+40191.2%
Total Assets

$8.32M

Previous: $76.1K+10836.0%
Stock-Based Comp

$244K

No prior period

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$76.7K

Q2 2022+162.9%vs Q2 2021
Beat estimate in 0 of 3 quarters(0%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro